Skip to main content

and
  1. Article

    Open Access

    Delirium and other neuropsychiatric manifestations of COVID-19 infection in people with preexisting psychiatric disorders: a systematic review

    Psychiatric disorders increase risk of neuropsychiatric disease and poor outcomes, yet little is known about the neuropsychiatric manifestations of COVID-19 in the psychiatric population. The primary objective...

    Emma A. van Reekum, Tea Rosic, Anjali Sergeant in Journal of Medical Case Reports (2021)

  2. Article

    Open Access

    A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder

    Patients with opioid use disorder (OUD) display an interindividual variability in their response to medications for opioid use disorder (MOUD). A genetic basis may explain the variability in this response. How...

    Caroul Chawar, Alannah Hillmer, Stephanie Sanger in Addiction Science & Clinical Practice (2021)

  3. Article

    Open Access

    Genetic basis of cannabis use: a systematic review

    With the increase in cannabis use rates, cannabis use disorder is being reported as one of the most common drug use disorders globally. Cannabis use has several known physical, psychological, and social advers...

    Alannah Hillmer, Caroul Chawar, Stephanie Sanger, Alessia D’Elia in BMC Medical Genomics (2021)

  4. Article

    Open Access

    GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: a systematic review and meta-analysis protocol

    The burden of opioid use disorder (OUD) has been increasing in North America. Administration of medication-assisted treatments (MATs) for OUD on an individual-dose basis has been shown to affect patient respon...

    Caroul Chawar, Alannah Hillmer, Stephanie Sanger, Alessia D’Elia in Systematic Reviews (2020)

  5. Article

    Open Access

    Genetic determinants of cannabis use: a systematic review protocol

    With the legalization of cannabis in Canada, there is an increase trend in use. Cannabis has been known to have several health implications, one of which is the development of cannabis use disorder (CUD). CUD ...

    Alannah Hillmer, Caroul Chawar, Stephanie Sanger, Alessia D’Elia in Systematic Reviews (2020)

  6. Article

    Open Access

    Feasibility of behavioral activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial

    Depression impacts the lives of millions of people worldwide. Behavioral activation (BA), derived from cognitive behavioral therapy, has the potential for improving depressive symptoms in patients with depress...

    Alessia D’Elia, Monica Bawor, Brittany B. Dennis in Pilot and Feasibility Studies (2020)